Table 1.
Demographic and clinical characteristics of HIV-infected paediatric patients attending the treatment failure programme in Khayelitsha, South Africa, in 2014
| Number of patients who qualified for the programme out of the total paediatric patient population | 140/465 | 30% |
| Number (percent) of patients enrolled in programme | 118 | 84% |
| Number (percent) of females | 52 | 44% |
| Median age (IQR) | 10 years | 5–14 |
| Median age at ART start (IQR) | 3.4 years | 0.6–7.2 |
| Median time on ART at enrolment (IQR) | 3.9 years | 2.5–7.5 |
| Median viral load in copies/ml on enrolment (IQR) | 13,141 | 2529–55,130 |
| Number (percent) who never achieved virologic suppression prior to enrolment | 39 | 33% |
| Number (percent) of patients on a non-nucleoside (NNRTI) regimen at enrolment | 36 | 30% |
| Number (percent) of patients on a protease inhibitor (PI) regimen at enrolment | 73 | 62% |
| Number (percent) of patients on 3TC monotherapy at enrolment | 5 | 4% |
| Number (percent) of patients not on ART at enrolment | 4 | 3% |
| Number (percent) of patients with a regimen change prior to enrolment | 24 | 20% |
| Median CD4 count in cells/µl at enrolment (IQR) | 687 | (449–1164) |
| Number (percent) of patients aged 10–15 years old fully disclosed to at enrolment | 48 | 80% |